Medtronic's Leadless Pacer Makes A Mark In Largest Trial To Date
This article was originally published in The Gray Sheet
Executive Summary
The firm expects just-reported positive pivotal trial results to support FDA approval of the tiny Micra pacemaker, which earned a CE mark in April. Micra is in a race with St. Jude’s Nanostim to become the first leadless pacemaker on the US market.